Hansoh Pharma – Talk Bio

Actionable Insights Powered by AI

Merck & Co. Enters Oral GLP-1 Market with $2 Billion Hansoh Pharma Deal

6 months ago talkbio0Tagged GLP-1 receptor, Hansoh Pharma, Merck & Co., Obesity, Oral cavity, Partnership, pharmaceutical collaboration

Merck & Co., Hansoh Pharma, GLP-1 receptor agonist, oral obesity treatment, pharmaceutical collaboration, biotech partnership

Merck Enters Obesity Market with $2 Billion Deal for Chinese Oral GLP-1 Drug

6 months ago talkbio0Tagged Benefit, cardiometabolic, Glucagon-Like Peptide 1, Hansoh Pharma, HS-10535, Merck, Obesity, Oral cavity, Weight Loss

Merck, Obesity, Oral GLP-1, Hansoh Pharma, HS-10535, Weight Loss, Cardiometabolic Benefits